INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 November 2010
|
Total net assets |
£99.4m |
|
NAV per share |
166.3p |
|
Share price |
137.0p |
|
Total value of unquoted investments |
£23.3m |
|
Total number of portfolio companies |
60 |
|
Cash |
1% NAV |
|
Cash committed and reserved to unquoted investments |
9% NAV |
|
Portfolio companies with < 1 year of cash |
10% NAV |
Top Ten Holdings
|
Company Name |
% NAV |
|
Celgene |
5.80 |
|
Micromet |
5.77 |
|
Amgen |
5.30 |
|
Shire Ltd |
5.16 |
|
Gilead Sciences |
4.83 |
|
Alexion Pharmaceuticals |
3.54 |
|
Teva |
3.43 |
|
Insulet |
3.39 |
|
Genzyme |
3.27 |
|
Cadent |
3.25 |
|
|
----------- |
|
Total |
43.74 |
|
Geographical Allocation |
% |
|
United States |
74 |
|
Europe |
23 |
|
Australia |
2 |
|
Cash |
1 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted allocation |
% |
|
Quoted |
76 |
|
Unquoted |
23 |
|
Cash |
1 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
17 DECEMBER 2010